| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |